GAIPET
Live / Registered — Registered (as of 28 Jan 2025)
What this means for you
Registered since 28 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79392554
- Registration number
- 7665734
- Mark type
- Word mark
- Filed
- 08 Nov 2023
- Published for opposition
- 10 Dec 2024
- Registered
- 28 Jan 2025
- Attorney of record
- Jonathan M. Rixen
Goods and services
- Class 001 — Chemicals: Chemical reagents, other than for medical or veterinary purposes; biological preparations for use in industry and science, other than for medical or veterinary purposes; diagnostic preparations for scientific use, other than for medical or veterinary purposes; test paper, chemical; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemicals preparations for scientific use; chemical substances for analyses in laboratories for scientific use, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purpose; biological preparations for cell culture, other than for medical or veterinary use; diagnostic reagents and preparations for scientific use except for medical and veterinary use; active chemical ingredients for use in the manufacture of pharmaceuticals for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia
- Class 005 — Pharmaceuticals: Medicines for human purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; biochemical medicines for the treatment of tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; pharmaceutical preparations for the treatment of tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; chemical reagents for medical and veterinary purposes; biological preparations for medical purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; reagent paper for medical purposes; drugs for medical purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; diagnostic preparations for medical purposes; vaccines
- Class 042 — Scientific and technological services: Scientific development and research services in the field of drugs; vaccine research and development services; scientific research and development of new products for others; scientific research; research of biochemistry; biotechnology research; pharmaceutical drug research; development services in the field of pharmaceutical drugs; medical research service; biomedical research services
Owner
Prosecution history
- 12 Sept 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 05 Sept 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 29 Aug 2025 — CORRECTION TRANSACTION RECEIVED FROM IB
- 27 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 15 Aug 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 15 Aug 2025 — FINAL DISPOSITION PROCESSED
- 29 Apr 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 28 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED